Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 11 to 20

MAXALT rizatriptan (as benzoate) 10mg tablet blister pack Cancelled under s30(1)(c)

27 January 2017

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
MAXALT rizatriptan (as benzoate) 5mg tablet blister pack Cancelled under s30(1)(c)

27 January 2017

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
MAXALT rizatriptan (as benzoate) 10mg tablet blister pack Cancelled under s30(1)(c)

27 January 2017

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
AusPAR: Human Papillomavirus 9 valent vaccine

16 January 2017

Australian public assessment report (AusPar)

Australian Public Assessment Report for Human Papillomavirus 9 valent vaccine
SCHERING-PLOUGH TESTOSTERONE testosterone 100mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
SCHERING-PLOUGH TESTOSTERONE testosterone 200mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
REMERON mirtazapine 15mg film coated tablets blister pack Cancelled under s30(1)(c)

12 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
REMERON mirtazapine 30mg film coated tablets blister pack Cancelled under s30(1)(c)

12 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
REMERON mirtazapine 45mg film coated tablets blister pack Cancelled under s30(1)(c)

12 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
TEMODAL temozolomide 100 mg powder for injection vial Cancelled under s30(1)(c)

12 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.